“Valeant Doesn’t Look Cheap” – Barron’sMay 9, 20160Comments by Kyle Guske II Over the weekend, Barron’s magazine featured our research for the fourth time in 2016 and 20th time since 2014. This time, Barron’s featured our research on Valeant Pharmaceuticals (VRX). See the Barron’s article here. In addition, you can see all our media coverage here. Leave a Reply Cancel Reply Your email address will not be published.